Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response.
Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Mirsaeidi M, et al. Among authors: baughman rp. Chest. 2015 Feb;147(2):e65-e66. doi: 10.1378/chest.14-2603. Chest. 2015. PMID: 25644926 Free PMC article. No abstract available.
Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide.
Cremers JP, Drent M, Bast A, Shigemitsu H, Baughman RP, Valeyre D, Sweiss NJ, Jansen TL. Cremers JP, et al. Among authors: baughman rp. Curr Opin Pulm Med. 2013 Sep;19(5):545-61. doi: 10.1097/MCP.0b013e3283642a7a. Curr Opin Pulm Med. 2013. PMID: 23880702 Review.
Sarcoidosis, fatigue, and sleep apnea.
Lower EE, Malhotra A, Sudurlescu V, Baughman RP. Lower EE, et al. Among authors: baughman rp. Chest. 2013 Dec;144(6):1976-1977. doi: 10.1378/chest.13-1761. Chest. 2013. PMID: 24297143 Free PMC article. No abstract available.
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group. Saketkoo LA, et al. Among authors: baughman rp. Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24. Thorax. 2014. PMID: 24368713 Free PMC article.
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.
Rituximab in the treatment of refractory pulmonary sarcoidosis.
Sweiss NJ, Lower EE, Mirsaeidi M, Dudek S, Garcia JG, Perkins D, Finn PW, Baughman RP. Sweiss NJ, et al. Among authors: baughman rp. Eur Respir J. 2014 May;43(5):1525-8. doi: 10.1183/09031936.00224513. Epub 2014 Jan 31. Eur Respir J. 2014. PMID: 24488568 Free PMC article. Clinical Trial. No abstract available.
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW. Judson MA, et al. Among authors: baughman rp. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):19-27. Sarcoidosis Vasc Diffuse Lung Dis. 2014. PMID: 24751450
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sweiss NJ, Noth I, Mirsaeidi M, Zhang W, Naureckas ET, Hogarth DK, Strek M, Caligiuri P, Machado RF, Niewold TB, Garcia JG, Pangan AL, Baughman RP. Sweiss NJ, et al. Among authors: baughman rp. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):46-54. Sarcoidosis Vasc Diffuse Lung Dis. 2014. PMID: 24751453 Free PMC article. Clinical Trial.
402 results